Related Experiment Video
Updated: May 11, 2025

Isolation and Expansion of Mesenchymal Stem/Stromal Cells Derived from Human Placenta Tissue
Published on: June 6, 2016
Human artificial placenta technology-trials: counselling and informed consent using healthcare professionals' and
Angret de Boer1,2, André Krom3, Rania Kalaai2
1Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands.
Insights
Ethical and legal issues must be resolved for the Artificial Amnion and Placenta Technology (AAPT) trials. Addressing these complexities ensures a responsible informed consent process for parents and healthcare professionals.
Area of Science:
- Medical Ethics
- Reproductive Technology
- Clinical Trial Design
Background:
- The Artificial Amnion and Placenta Technology (AAPT) aims to improve outcomes for extremely premature infants.
- First-in-human trials are anticipated, necessitating empirical research with stakeholders.
- This study addresses crucial legal and ethical considerations for AAPT trial counselling and informed consent.
Purpose of the Study:
- To explore stakeholder perspectives on counselling and informed consent for AAPT trials.
- To identify key ethical and legal issues influencing the informed consent process.
- To inform the responsible design of future AAPT clinical trials.
Main Methods:
- A qualitative study design was employed.
- Individual and focus group interviews were conducted with healthcare professionals (HCPs) and parents.
- Thematic analysis was used to analyze interview data.
Main Results:
- Fifteen parents and 46 HCPs participated.
- Key themes emerged regarding the moral/legal status of participants, the pregnant person's role, and technology terminology.
- Interconnected factors influencing counselling and informed consent, including parental hope, were identified.
Conclusions:
- Resolving ethical and legal issues is vital for establishing parental rights and a sound informed consent process.
- Navigating complexities like participant moral status and rights is essential before trial progression.
- Establishing consensus and open dialogue among stakeholders is crucial for a robust ethical framework.
Background:
The Artificial Amnion and Placenta Technology (AAPT) is developed to improve outcomes of extremely premature birth, with first in-human trials expected in the coming years. Empirical research with key stakeholders is essential for responsibly designing these trials. This study aims to discuss considerations for counselling and informed consent for the first in-human trials of the AAPT, discussing legal and ethical considerations.
Methods:
A qualitative study using both individual and focus group interviews with healthcare professionals (HCPs) and parents was performed. Interviews were thematically analysed.
Results:
Fifteen parents and 46 HCPs were interviewed. The results are represented into key themes reflecting participants' perspectives on: (I) the moral and legal status of the subject treated in AAPT trials, (II) the first participant: the pregnant person, and (III) the terminology used to describe the technology. Furthermore, considerations around the informed consent process and counselling, including parental hope, are described. The findings suggest these factors are interconnected, as the moral and legal context surrounding AAPT trials influences the approach to counselling and informed consent.
Conclusion:
Resolving key ethical and legal issues important for counselling and informed consent is essential for establishing parental right and the development of a responsible, ethically sound informed consent process.
Impact:
Addressing ethical and legal issues surrounding counseling and informed consent is essential to safeguard a responsible and ethically sound consent process for future human artificial amnion and placenta technology (AAPT)-trials. This is the first study exploring stakeholder perspectives on the AAPT, highlighting the complexities in counselling and informed consent, such as the moral status of participants and the rights of all parties, which must be carefully navigated before trial designs can progress. The article underscores the importance of establishing consensus and maintaining open dialogue among all stakeholders to create a robust, ethically grounded framework for informed consent in future trials.
More Related Videos
12:17The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
08:08Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
Related Concept Videos
Ethics in Research
Induced Pluripotent Stem Cells
Stem Cell Culture
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Nurses' Legal Responsibilities I
The legal responsibilities of a nurse regarding informed consent include the following:
Ethical Dilemmas II